Downregulation of miR-34a potentially contributes to altered lipid metabolism in nonalcoholic fatty liver disease (NAFLD) by regulating its targets, PPARα and SIRT1 [21]. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.